Tiago Felismino

7PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 08, 2026
Tumour-Associated Neutrophils in Colorectal Cancer: a Systematic Review, Meta-analysis, and Comprehensive Literature Review.

|Jun 24, 2026
Real-World Epidemiology, Treatment Patterns, and Outcomes of Hepatocellular Carcinoma in Brazil: A Multicenter Retrospective Study.

|May 22, 2026
Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer.

|Aug 19, 2025
Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Biomarker in Advanced Hepatocellular Carcinoma Treated with First-Line Immunotherapy.

Tiago Felismino, Luanna Martins, Matheus Barroso

|Jul 17, 2025
Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis.

Tiago Cordeiro Felismino, Diego Rodrigues, Angelo Brito

|Jun 11, 2019
Primary Tumor Location Is a Predictor of Poor Prognosis in Patients with Locally Advanced Esophagogastric Cancer Treated with Perioperative Chemotherapy.

Tiago Cordeiro Felismino, Audrey Cabral Ferreira de Oliveira, Ana Caroline Fonseca Alves

Pageof 2

Frequent Collaborators

1 joint publications

Diogo Diniz Gomes Bugano

1 joint publications

Elice Carneiro Batista

1 joint publications

Italo Fernandes

1 joint publications

Gustavo Sanches Faria Pinto